Christenson, J., Trepel, J., Ali, H., Lee, S., , Baskin-Bey, E., … Richer, J. (2018). Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast Cancer. Hormones & Cancer. https://doi.org/10.1007/s12672-017-0314-5 (Original work published 2018)

Lee, J., Nair, J., Zimmer, A., Lipkowitz, S., Annunziata, C., Merino, M., … Kohn, E. (2018). Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 study. The Lancet. Oncology. https://doi.org/10.1016/S1470-2045(18)30009-3 (Original work published 2018)